Related Experiment Videos
Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis.
R Oberbeck1, M Dahlweid, R Koch
1Department of Trauma Surgery, University Hospital of Essen, Essen, Germany.
Critical Care Medicine
|March 14, 2001
Summary
Dehydroepiandrosterone (DHEA) administration significantly improved survival in a mouse model of sepsis. This steroid hormone enhanced T-cell immunity and reduced pro-inflammatory cytokine release, suggesting a potential benefit in systemic inflammation.
Area of Science:
- Immunology
- Endocrinology
- Sepsis Research
Background:
- Sepsis severely impairs cellular immune function.
- Dehydroepiandrosterone (DHEA) is a steroid hormone with proposed immunoenhancing properties.
Purpose of the Study:
- To investigate the effect of DHEA on mortality and cellular immune function in an experimental sepsis model.
- To determine if DHEA administration can mitigate the immune suppression associated with sepsis.
Main Methods:
- Male NMRI mice underwent cecal ligation and puncture (CLP) to induce sepsis or a sham procedure.
- Mice received subcutaneous DHEA (30 mg/kg) or a vehicle control.
- Survival, white blood cell counts, serum cytokine levels (TNF-alpha, IL-1beta), and delayed-type hypersensitivity (DTH) response were assessed 48 hours post-CLP.
Main Results:
- DHEA administration significantly increased survival rates in septic mice (87% vs. 53% at 48 hours; p <.001).
- DHEA treatment restored the suppressed DTH response and reduced serum TNF-alpha concentrations.
- Clinical variables were monitored, showing improvements with DHEA treatment.
Conclusions:
- DHEA administration enhances survival following a septic challenge in mice.
- The immunoenhancing effects of DHEA involve reduced TNF-alpha release and improved T-cell mediated immunity.
- DHEA may be a beneficial therapeutic agent for managing systemic inflammation and sepsis.